NCT06731114 "Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'
| NCT ID | NCT06731114 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Cervicogenic Headache |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2024-07-15 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised control trial and the purpose of this study is to determine the "Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache".
Eligibility Criteria
Inclusion Criteria * Participants will be included according to international classification of headache criteria which includes: * Headache with neck stiffness * Headache at least once a month in the last 3 months * Headache with at least 4 score in Numeric Pain Rating Scale(NPRS) * Unilateral headache with no shift of side * Positive flexion rotation test (Rotation restriction is greater than 10 degrees) * C1-C2 dysfunction * Headache precipitated by sustained neck movements,myofacial trigger points palpation in neck * Age group 18-45 * Both male and female Exclusion Criteria: * Cervical spondylosis * Headache of non-cervical origin * Dizziness or visual disturbance * Cervical radiculopathy/ nerve root involvement/ disc herniation * Cervical instability/ fracture * Vertebrobasilar insufficiency * Thoracic outlet syndrome * Cervical spine surgery * Cervical spondylolisthesis * Spinal infection or tumors * Osteoporosis * meningitis * subarachnoid hemorrhage
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06731114 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Cervicogenic Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06731114 currently recruiting?
Yes, NCT06731114 is actively recruiting participants. Contact the research team at aesharshad4200@gmail.com for enrollment information.
Where is the NCT06731114 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT06731114 clinical trial?
NCT06731114 is sponsored by Foundation University Islamabad. The trial plans to enroll 54 participants.